Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: a longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics.

Stephanie Feleus,Maaike van der Lee,Jesse J Swen,Raymund A C Roos,Susanne T de Bot

Therapeutic advances in rare disease（2023）

引用 0|浏览3

暂无评分

摘要

This study is registered in the International Clinical Trial Registry Platform under registration number NL8251, URL https://trialsearch.who.int/Trial2.aspx?TrialID=NL8251.

查看译文

关键词

huntingtons,medication use,drug treatment,hd-med

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要